Published in Acta Otolaryngol on November 01, 2009
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med (2004) 17.91
Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet (2006) 11.64
Bariatric surgery and long-term cardiovascular events. JAMA (2012) 7.11
Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med (2012) 6.19
Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol (2009) 5.37
Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea. Am J Respir Crit Care Med (2008) 3.80
Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology (2009) 3.67
Sleep duration and breast cancer: a prospective cohort study. Cancer Res (2005) 3.26
Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol (2009) 3.14
Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res (2005) 2.91
Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep (2009) 2.89
AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One (2012) 2.67
Endothelial function is well preserved in obese patients with mild obstructive sleep apnea. Sleep Breath (2013) 2.67
Sleep and mortality: a population-based 22-year follow-up study. Sleep (2007) 2.52
Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care (2010) 2.50
Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care (2008) 1.95
Trends in self-reported sleep duration and insomnia-related symptoms in Finland from 1972 to 2005: a comparative review and re-analysis of Finnish population samples. J Sleep Res (2008) 1.94
National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health (2007) 1.92
Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2008) 1.83
Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr (2012) 1.80
Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women - The FIN-D2D survey. Sleep Med (2007) 1.78
The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke (2005) 1.76
Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial. PLoS One (2009) 1.68
Sustained improvement in mild obstructive sleep apnea after a diet- and physical activity-based lifestyle intervention: postinterventional follow-up. Am J Clin Nutr (2010) 1.67
Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care (2012) 1.66
Sleepiness at the wheel across Europe: a survey of 19 countries. J Sleep Res (2015) 1.54
Health care use during 20 years following bariatric surgery. JAMA (2012) 1.52
Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study. Diabetes Care (2008) 1.51
A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med (2004) 1.42
The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine (2012) 1.41
Sleep duration, lifestyle intervention, and incidence of type 2 diabetes in impaired glucose tolerance: The Finnish Diabetes Prevention Study. Diabetes Care (2009) 1.34
High expression of complement components in omental adipose tissue in obese men. Obes Res (2003) 1.34
Insomnia and global sleep dissatisfaction in Finland. J Sleep Res (2002) 1.33
Heritability of diurnal type: a nationwide study of 8753 adult twin pairs. J Sleep Res (2007) 1.33
Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity. Sleep (2007) 1.33
Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol Int (2013) 1.31
Self-reported sleep duration, all-cause mortality, cardiovascular mortality and morbidity in Finland. Sleep Med (2011) 1.30
Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective. Int J Technol Assess Health Care (2007) 1.30
A systematic evaluation of factors associated with nocturia--the population-based FINNO study. Am J Epidemiol (2009) 1.29
Silicone tubing is not necessary after primary endoscopic dacryocystorhinostomy: a prospective randomized study. Am J Rhinol (2008) 1.22
Leisure-time physical activity and the metabolic syndrome in the Finnish diabetes prevention study. Diabetes Care (2010) 1.22
Shift-work and cardiovascular disease: a population-based 22-year follow-up study. Eur J Epidemiol (2010) 1.21
Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial. Sleep Med (2008) 1.20
High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population. BMC Public Health (2008) 1.15
Adults with ADHD benefit from cognitive-behaviorally oriented group rehabilitation: a study of 29 participants. J Atten Disord (2008) 1.15
Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health (2011) 1.14
Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies. Am J Gastroenterol (2003) 1.14
Long-term consistency of diurnal-type preferences among men. Chronobiol Int (2013) 1.13
Reducing the risk of type 2 diabetes with nutrition and physical activity - efficacy and implementation of lifestyle interventions in Finland. Public Health Nutr (2010) 1.09
Heritability and mortality risk of insomnia-related symptoms: a genetic epidemiologic study in a population-based twin cohort. Sleep (2011) 1.08
The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement (2013) 1.07
Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck (2013) 1.07
Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med (2002) 1.06
Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey. BMC Public Health (2010) 1.05
Relation of chronotype to sleep complaints in the general Finnish population. Chronobiol Int (2012) 1.05
Telomere length in circulating leukocytes is associated with lung function and disease. Eur Respir J (2013) 1.04
The increasing prevalence of metabolic syndrome among Finnish men and women over a decade. J Clin Endocrinol Metab (2007) 1.03
Longitudinal study on poor sleep and life dissatisfaction in a nationwide cohort of twins. Am J Epidemiol (2008) 1.03
Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D). Prim Care Diabetes (2010) 1.02
Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant. PLoS One (2012) 1.02
Depot-specific expression of fibroblast growth factors in human adipose tissue. Obes Res (2002) 1.01
A dietary and behavioural programme for the treatment of obesity. A 4-year clinical trial and a long-term posttreatment follow-up. J Intern Med (2003) 1.00
The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. J Sleep Res (2009) 0.99
Weight reduction and increased physical activity to prevent the progression of obstructive sleep apnea: A 4-year observational postintervention follow-up of a randomized clinical trial. [corrected]. JAMA Intern Med (2013) 0.99
Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score. Diabetes Res Clin Pract (2009) 0.98
Hypopharyngeal carcinoma in Finland from 1990-1999. Eur Arch Otorhinolaryngol (2004) 0.98
Prevalence, awareness and treatment of hypertension in Finland during 1982-2007. J Hypertens (2009) 0.98
State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome. Mov Disord (2007) 0.98
Alcohol consumption and alcohol problems after bariatric surgery in the Swedish obese subjects study. Obesity (Silver Spring) (2013) 0.98
Childhood adversities and quality of sleep in adulthood: A population-based study of 26,000 Finns. Sleep Med (2009) 0.97
Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study. Sleep Med (2010) 0.97
Symptom score questionnaire for nasolacrimal duct obstruction in adults--a novel tool to assess the outcome after endoscopic dacryocystorhinostomy. Rhinology (2010) 0.97
The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J Am Coll Cardiol (2005) 0.96
No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. PLoS One (2013) 0.96
Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Diabetes (2006) 0.96
Automatic sleep-wake and nap analysis with a new wrist worn online activity monitoring device vivago WristCare. Sleep (2003) 0.95
Leukocyte telomere length in the Finnish Diabetes Prevention Study. PLoS One (2012) 0.95
Evening types are prone to depression. Chronobiol Int (2013) 0.95
Obesity and obstructive sleep apnea--clinical significance of weight loss. Sleep Med Rev (2012) 0.95
Associations of reported bruxism with insomnia and insufficient sleep symptoms among media personnel with or without irregular shift work. Head Face Med (2008) 0.94
Silicone tubing after endoscopic dacryocystorhinostomy: is it necessary? Am J Rhinol (2006) 0.94
Socioeconomic position and effectiveness of lifestyle intervention in prevention of type 2 diabetes: one-year follow-up of the FIN-D2D project. Scand J Public Health (2011) 0.93
Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression. BMC Cancer (2011) 0.93
Impact of blood pressure and insulin on the relationship between body fat and left ventricular structure. Eur Heart J (2003) 0.93
Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation. Vaccine (2012) 0.93
A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance. Sleep Med (2009) 0.92